In the year after starting treatment, Ozempic users with a previous diagnosis of tobacco use disorder were up to 32% less likely to discuss tobacco use with a healthcare provider than those taking other diabetes medications. This was true even compared with those taking medicines in the same class, known as GLP-1 receptor agonists, researchers reported in Annals of Internal Medicine.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/P3I9T6g
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment